MAGNESIUM SULFATE IS COMMONLY ADMINISTERED TO WOMEN WITH PRE-ECLAMPSIA. WHAT IS THE PRIMARY GOAL OF THIS THERAPY

• A. To lower the BP
• B. To prevent preterm labor
• C. For neuroprotection of the fetus
• D. To prevent seizures ✓
• E. To dilate the cerebral vasculature and prevent headache

• Pre-eclampsia is a serious condition that can occur during pregnancy, characterized by high blood pressure and often the presence of protein in the urine.
• Magnesium sulfate is commonly administered to women with pre-eclampsia as it has been shown to be effective in preventing seizures, which is a severe complication of pre-eclampsia known as eclampsia.
• The primary goal of administering magnesium sulfate in this context is to prevent the occurrence of seizures in women with pre-eclampsia, rather than specifically lowering blood pressure, preventing preterm labor, providing neuroprotection to the fetus, dilating cerebral vasculature to prevent headaches.
• Magnesium sulfate works by acting as a central nervous system depressant and anticonvulsant, reducing the risk of seizures in women with pre-eclampsia.

In summary, the primary goal of administering magnesium sulfate therapy to women with pre-eclampsia is to prevent seizures, which are a potentially life-threatening complication of this condition.

In other words, Magnesium sulfate is commonly used as a treatment for preventing seizures in women with pre-eclampsia, a condition characterized by high blood pressure and proteinuria during pregnancy. This therapy is crucial in managing the potentially life-threatening complications associated with pre-eclampsia, such as eclampsia, which involves the occurrence of seizures.